Cosmax, Inc. (192820.KS)
- Previous Close
196,100.00 - Open
195,000.00 - Bid 195,400.00 x --
- Ask 196,000.00 x --
- Day's Range
191,000.00 - 200,000.00 - 52 Week Range
116,000.00 - 208,000.00 - Volume
136,798 - Avg. Volume
97,376 - Market Cap (intraday)
2.218T - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 2,300.00 (1.17%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
212,666.67
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.
www.cosmax.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 192820.KS
View MorePerformance Overview: 192820.KS
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 192820.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 192820.KS
View MoreValuation Measures
Market Cap
2.22T
Enterprise Value
2.69T
Trailing P/E
25.93
Forward P/E
19.30
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.03
Price/Book (mrq)
4.70
Enterprise Value/Revenue
1.24
Enterprise Value/EBITDA
10.67
Financial Highlights
Profitability and Income Statement
Profit Margin
3.96%
Return on Assets (ttm)
6.07%
Return on Equity (ttm)
20.39%
Revenue (ttm)
2.17T
Net Income Avi to Common (ttm)
85.8B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
288.65B
Total Debt/Equity (mrq)
147.23%
Levered Free Cash Flow (ttm)
-87.01B